(±)-PotassiuM citraMalate Monohydrate
![]() |
- $143 - $499.64
- Product name: (±)-PotassiuM citraMalate Monohydrate
- CAS: 1030365-02-6
- MF: C5H9KO5
- MW: 188.22
- EINECS:
- MDL Number:MFCD18252952
- Synonyms:(±)-PotassiuM citraMalate Monohydrate;2-Hydroxy-2-methylbutanedioic acid dipotassium salt;Potassium 2-hydroxy-2-methylsuccinate;(+/-)-Potassium citramalate monohydrate;Endogenous Metabolite,inhibit,Potassium 2 hydroxy 2 methylsuccinate,Inhibitor,Potassium 2hydroxy2methylsuccinate;(+/-)-potassium citramalate monohydrate, >=97.0% (nt)
3 prices
Selected condition:
Brand
- Adipogen Life Sciences
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5MG
- 1g
- 5G
- ManufacturerAdipogen Life Sciences
- Product numberCDX-P0157-G005
- Product description(±)-Potassium citramalate monohydrate ≥97%(NT)
- Packaging5G
- Price$259
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0163668
- Product description(+/-)-2-HYDROXY-2-METHYLSUCCINIC ACIDDIPOTASSIUM SALT 95.00%
- Packaging5MG
- Price$499.64
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product number27455
- Product description(±)-Potassium citramalate monohydrate ≥97.0% (NT)
- Packaging1g
- Price$143
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Adipogen Life Sciences | CDX-P0157-G005 | (±)-Potassium citramalate monohydrate ≥97%(NT) | 5G | $259 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0163668 | (+/-)-2-HYDROXY-2-METHYLSUCCINIC ACIDDIPOTASSIUM SALT 95.00% | 5MG | $499.64 | 2021-12-16 | Buy |
Sigma-Aldrich | 27455 | (±)-Potassium citramalate monohydrate ≥97.0% (NT) | 1g | $143 | 2024-03-01 | Buy |
Properties
form :Solid
color :White to off-white
color :White to off-white
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|